Nutriband Inc. Secures Costa Rica Market Approval for Kinesiology Tape Products

Nutriband Inc. (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale in the Central American market. The regulatory approval process was overseen and financed by the company's exclusive distribution partner in the region, Innomedica CCB. This development represents a significant step in Nutriband's international expansion strategy, providing the company with regulatory clearance to market its kinesiology tape products throughout Costa Rica.

Following the regulatory approval, Nutriband plans to intensify marketing efforts in partnership with Innomedica CCB. The company will target both its newly approved kinesiology tape products and its existing mosquito repellent patch line in the Costa Rican market. This dual-product approach allows Nutriband to leverage its distribution partnership across multiple product categories, potentially increasing market penetration and revenue opportunities in the region. The company's broader corporate strategy includes developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating proprietary AVERSA™ technology designed to prevent misuse of drugs with abuse potential.

The regulatory approval in Costa Rica comes as Nutriband continues to expand its international presence and product offerings. While the company's primary focus remains on pharmaceutical transdermal products, the kinesiology tape line represents a complementary consumer health product that can be marketed alongside its more specialized pharmaceutical offerings. The partnership with Innomedica CCB provides Nutriband with local expertise and financial support for regulatory processes, which can be particularly valuable when entering new international markets with different regulatory requirements and market dynamics.

This announcement follows the company's ongoing efforts to build its product portfolio and expand its geographic reach. Investors and stakeholders can find additional information about Nutriband's developments through the company's newsroom at https://ibn.fm/NTRB. The regulatory approval in Costa Rica represents a tangible step forward in the company's international expansion strategy and provides a foundation for potential future growth in Central American markets. As Nutriband continues to develop its pharmaceutical pipeline while expanding its consumer health products, regulatory approvals like this one in Costa Rica help establish the infrastructure necessary for broader international distribution of its product lines.